Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (3), 2057-2066
- https://doi.org/10.1074/jbc.m110.147306
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1FEBS Letters, 2009
- A Regulatory Mechanism for RSK2 NH2-Terminal Kinase ActivityCancer Research, 2009
- Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic TransformationMolecular and Cellular Biology, 2009
- Cyclin-Dependent Kinase 3–Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell TransformationCancer Research, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell TransformationCancer Research, 2007
- RSK2 Mediates Muscle Cell Differentiation through Regulation of NFAT3Journal of Biological Chemistry, 2007
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sitesOncogene, 2000
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993